Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SARGRAMOSTIM vs SEBELIPASE ALFA: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

SARGRAMOSTIM vs SEBELIPASE ALFA: Safety Overview

Metric SARGRAMOSTIM SEBELIPASE ALFA
Total FAERS Reports 593 614
Deaths Reported 85 43
Death Rate 14.3% 7.0%
Hospitalizations 138 124
Average Patient Age 34.4 yrs 8.8 yrs
% Female Patients 43.5% 51.3%
Manufacturer Partner Therapeutics, Inc. Alexion Pharmaceuticals, Inc.
Route INTRAVENOUS INTRAVENOUS
Marketing Status Prescription Prescription